Back to Search
BRUCE BROCKSTEIN, MD
Medical Oncology Physician
NPI: 1740349695IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
036086058(IL)
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 1990
Research & Publications (20)
The role of inhibitors of the epidermal growth factor in management of head and neck cancer.
PMID 18691458·J Natl Compr Canc Netw·2008
6-review
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.
PMID 15277256·Ann Oncol·2004
4-observational
Organ preservation for advanced head and neck cancer concomitant chemoradiation.
PMID 12619544·Cancer Treat Res·2003
6-review
Radiation-induced leiomyosarcoma: does antimetabolite chemotherapy contribute? A report of three cases.
PMID 18521382·Sarcoma·2003
8-other
Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled?
PMID 10841194·Curr Opin Oncol·2000
8-other
Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer.
PMID 11561683·Invest New Drugs·2001
3-trial
Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors.
PMID 10808211·Bone Marrow Transplant·2000
8-other
A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer.
PMID 10942062·Ann Oncol·2000
3-trial
Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group.
PMID 19634157·Cancer·2009
3-trial
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
PMID 19451436·J Clin Oncol·2009
3-trial
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.
PMID 18539617·Ann Oncol·2008
3-trial
A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores.
PMID 17922221·Qual Life Res·2007
2-rct
A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
PMID 16520986·Cancer Chemother Pharmacol·2006
3-trial
Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation.
PMID 16302193·Head Neck·2006
8-other
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
PMID 16849759·J Clin Oncol·2006
3-trial
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
PMID 16322304·Clin Cancer Res·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2650 RIDGE AVE
EVANSTON, IL 60201 - Phone
- (847) 570-2112
Quick Facts
- NPI
- 1740349695
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile